跳至主要内容
临床试验/ACTRN12620001028998
ACTRN12620001028998已完成未知

Investigating the Efficacy of Chest Pressure for Direct Current Cardioversion in Atrial Fibrillation: A Randomised Control Trial (Pressure-AF)

Cardiovascular Department, John Hunter Hospital0 个研究点目标入组 311 人开始时间: 2020年10月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
311

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Has atrial fibrillation
  • Age 18 or older
  • Referred for direct current cardioversion
  • Three weeks of therapeutic anti-coagulation prior to cardioversion or trans-oesophageal echocardiography to exclude left atrial appendage thrombus.

排除标准

  • Pregnancy or Breastfeeding
  • Inability to provide informed consent
  • Other atrial tachyarrhythmias (atrial flutter of multifocal atrial tachycardia)
  • Medical comorbidity where anticoagulation is contra-indicated

研究者

发起方
Cardiovascular Department, John Hunter Hospital

相似试验